Commercialization – The Cancer Nanotechnology Commercialization Working Group facilitates technology development and commercialization. This group brings together a broad range of expertise in intellectual property, patent law, and technology commercialization to (1) pro-actively monitor research developments, (2) assess commercialization potential, and (3) provide continuous support through the commercialization process. Our objectives are two-fold: (1) to identify technologies with potential for commercialization at an early stage, and (2) to provide comprehensive cradle-to-grave support during the commercialization process.

CCNE Technology

For more information about the following technology, contact John Fini, Director of IP and Technology Commercialization at jfini@jhu.edu.